Home/Filings/4/0001372514-23-000150
4//SEC Filing

Tosca Melissa 4

Accession 0001372514-23-000150

CIK 0001372514other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:49 PM ET

Size

7.7 KB

Accession

0001372514-23-000150

Insider Transaction Report

Form 4
Period: 2023-09-29
Transactions
  • Award

    Stock Option (right to buy)

    2023-09-29+60,00060,000 total
    Exercise: $0.57From: 2023-09-29Exp: 2033-09-29Common Stock (60,000 underlying)
  • Award

    Common Stock

    2023-09-29+30,00034,900 total
Footnotes (2)
  • [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date.
  • [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.

Issuer

KIORA PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1
  • filerCIK 0001947184

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:49 PM ET
Size
7.7 KB